Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | FPR2 | P25090 | 3/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359065 | 1.00 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL359064 | 1.00 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL7775372 | 1.00 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL6026558 | 1.00 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL6026559 | 1.00 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL9502850 | 1.00 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15692297 | 0.92 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL9073718 | 0.87 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL9073717 | 0.87 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL10866724 | 0.86 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1KMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503719-B2 | Metabolomic characterization of microorganisms | LEWIS IAN ANDREW (CA) | 2025-12-23 | — | — | US | claimed |
| US-12076432-B2 | Method of repairing oxidatively treated hair | CONOPCO, INC. (US) | 2024-09-03 | — | — | US | claimed |
| CN-115894143-B | Palladium catalyzed double ligand unguided preparation method for deuterated aromatic compound | 宁波萃英化学技术有限公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2024030909-A1 | BIOMARKERS OF AMINO ACID COMPOSITION TREATMENT RESPONSE IN LONG COVID | AXCELLA HEALTH INC. (US) | 2024-02-08 | — | — | WO | claimed |
| WO-2024026307-A1 | BIOMARKER FOR LONG COVID AND FATIGUE | AXCELLA HEALTH INC. (US) | 2024-02-01 | — | — | WO | claimed |
| US-20230390346-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | BIOMEDIT, LLC | 2023-12-07 | — | — | US | claimed |
| US-20230368914-A1 | SYSTEMS AND METHODS FOR COMPUTER-IMPLEMENTED METABOLITE ANALYSIS AND PREDICTION FOR ANIMAL SUBJECTS | DSM IP ASSETS B.V. (NL) | 2023-11-16 | — | — | US | claimed |
| EP-4216726-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | Biomedit, LLC (US) | 2023-08-02 | — | — | EP | claimed |
| CN-116507349-A | Probiotic bacillus compositions and methods of use | 生物编辑有限责任公司 | 2023-07-28 | — | — | CN | claimed |
| EP-3967703-B1 | CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATION MATERIAL AND CULTURE MEDIUM | FUJIFILM CORP (JP) | 2023-07-26 | — | — | EP | claimed |
| US-20060063827-A1 | Systemic administration of therapeutic amino acids and N-acetylamino acids | YU RUEY J | 2006-03-23 | — | — | US | claimed |
| EP-1570840-A2 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2005-09-07 | — | — | EP | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | claimed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| US-5902826-A | WATER SOLUBLE DIAMINE-PLATINUM (IV) COMPLEX; SIDE EFFECT REDUCTION, WATER SOLUBLE, TREATMENT OF MALIGNANT TUMORS | SS PHARMACEUTICAL CO., LTD. (JP) | 1999-05-11 | — | — | US | claimed |
| EP-0864578-A2 | Platinum (IV) complex and pharmaceutical composition comprising the same | SS PHARMACEUTICAL CO., LTD. (JP) | 1998-09-16 | — | — | EP | claimed |
| US-5519000-A | OLIGOPEPTIDE | CENTECOR, INC. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |